bioAffinity Technologies, Inc. (US: BIAF) — Healthcare · Share Price, Chart & Market Data
About: bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: $2.23 (-3.04%)
BIAFbioAffinity Technologies, Inc.
Loading watchlist status…
Trade BIAF now
bioAffinity Technologies, Inc. share price
BIAF price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:05 am GMT+0
BIAF price performance
-14.559%
5D
-44.25%
1M
82.787%
YTD
-84.178%
1Y
BIAF price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:05 am GMT+0
BIAF details
BIAF Market Signals